AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis
Shari S. Rogal, Lissi Hansen, Arpan Patel, Nneka N. Ufere, Manisha Verma, Christopher D. Woodrell, Fasiha Kanwal – 31 January 2022
Discovery of an insulin‐induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element‐binding protein–mediated lipogenesis
Shi‐You Jiang, Xinglin Yang, Zimo Yang, Jue‐Wan Li, Meng‐Qiang Xu, Yu‐Xiu Qu, Jing‐Jie Tang, Yun‐Feng Li, Liguo Wang, Yi‐Wen Shao, Xin‐Yuan Meng, Huili Hu, Bao‐Liang Song, Yu Rao, Wei Qi – 30 January 2022
Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis
Heejoon Jang, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Joon Yeul Nam, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon – 30 January 2022
Letter to the editor: Spontaneous regression of cirrhosis: A paradigm shift in our understanding of the natural history of NASH
Arka De, Amarjit Keisham, Ajay Duseja – 30 January 2022
Healthy peribiliary glands are necessary for successful liver transplantation
Heather Francis, Debjyoti Kundu, Leonardo Baiocchi – 30 January 2022
Reply
Arun J. Sanyal, Chuhan Chung, Robert P. Myers, Jaime Bosch – 30 January 2022
Letter to the editor: Leveraging universal adult vaccination as part of a multipronged approach to eliminate hepatitis B in the USA
Vivian Huang, Clem Lewin, Patricia Novy – 30 January 2022
Intraoperative risk factors of acute kidney injury after liver transplantation
Rachel J. Berkowitz, Milo C. Engoren, Graciela Mentz, Pratima Sharma, Sathish S. Kumar, Ryan Davis, Sachin Kheterpal, Christopher J. Sonnenday, Nicholas J. Douville – 30 January 2022 – Acute kidney injury (AKI) is one of the most common complications of liver transplantation (LT). We examined the impact of intraoperative management on risk for AKI following LT. In this retrospective observational study, we linked data from the electronic health record with standardized transplant outcomes.
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study
Serena Del Turco, Valentina Cappello, Christos Tapeinos, Aldo Moscardini, Laura Sabatino, Matteo Battaglini, Fabio Melandro, Francesco Torri, Caterina Martinelli, Serena Babboni, Beatrice Silvestrini, Riccardo Morganti, Mauro Gemmi, Paolo De Simone, Paulo N. Martins, Laura Crocetti, Adriano Peris, Daniela Campani, Giuseppina Basta, Gianni Ciofani, Davide Ghinolfi – 30 January 2022 – The combined approach of ex situ normothermic machine perfusion (NMP) and nanotechnology represents a strategy to mitigate ischemia/reperfusion injury in liver transplantation (LT).